Senior insider sale
Chief Financial Officer at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$555.3K
75K shares
What this filing means
SECORA MICHAEL plans to sell 75K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $555.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/14/2025ACC: 0001959173-25-000298
Officer· Chief Financial Officer
Since Apr 2021
75K
Shares to sell
$555.3K
Approx. market value
15K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months2
Stock Option Exercise
Cash
8/16/2023
14.39KStock Option Exercise
Cash
8/15/2023
607.00Total acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/16/2023 | Stock Option Exercise Cash | 14.39K | — |
8/15/2023 | Stock Option Exercise Cash | 607.00 | — |
| Total | 15K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
15K
Market value
$112.2K
12/11/2024
—Completed
Units to sell
15K
Market value
$116.3K
12/10/2024
—Completed
Units to sell
15K
Market value
$114.9K
11/13/2024
—Completed
Units to sell
15K
Market value
$114.6K
11/12/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
15K
Market value
$97.2K
1/14/2025
Total
Units
75K
Value
$555.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/11/2024 | 15K | $112.2K | — | Completed |
12/10/2024 | 15K | $116.3K | — | Completed |
11/13/2024 | 15K | $114.9K | — | Completed |
11/12/2024 | 15K | $114.6K | — | Completed |
| Planned — Approximate Date | ||||
1/14/2025 | 15K | $97.2K | NASDAQ | Planned |
| Total | 75K | $555.3K | ||